JFD Brokers Logo
Novartis Is Trying To Find A “Cure” For Its Stock

Novartis Is Trying To Find A “Cure” For Its Stock

2019/10/17
12:32
Darius Anucauskas

Darius Anucauskas

JFD Research, Technical Analysis

After its reversal to the downside on July 19th, the Novartis AG stock (NYSE: NVS) had drifted lower and fell below its 200-day EMA. After declining for a few months and trading below its medium-term downside resistance taken from the high of that reversal day, the price started rising again and yesterday it briefly broke above that line. That said, NVS still closed the trading session below the downside line, but given that the upside momentum started picking up, there is a chance we may see another outburst higher. However, in order to get comfortable with higher areas, not only that we need to see a break of the above-mentioned downside line, but also a daily close above the 87.77 barrier. We will take a neutral stance for now and wait for a clear break of one of our levels first, before examining a further directional move.

If eventually we get a break of that downside line and the price closes the day above the 87.77 barrier, marked by the high of September 20th, this would confirm a forthcoming higher high and would place the stock above the 200-day EMA. Such a move might attract more buyers into the game and NVS could then be lifted to the 89.55 hurdle, which is the high of September 12th. If the buying doesn’t stop there, the next stop for the price might be the 90.96 level, marked by the high of August 30th. This is where the stock could stall temporarily.

Our oscillators, the RSI and the MACD, are somewhat in support of the above-discussed scenario. The RSI had showed us signs of bottoming, it travelled fractionally above 50 and is pointing a bit to the upside. The MACD has also started pointing a bit to the upside and has moved above its trigger line. That said, the indicator still remains in the negative territory. So, on one hand, the RSI is suggesting that there might be some upside coming up, but the negative MACD is one of the reasons why we will stay neutral for now.

Alternatively, if the stock continues to trade below the aforementioned downside line and the price slides below the 85.58 zone, marked by the low of this week, this could open the door for a further moves south. We might then target the 83.94 support area, which is currently the lowest point of October. Initially, NVS may get a hold-up around there, or even correct back up a bit. That said, if there are still no new buying seen in that price range, this could lead to a few investors liquidating some of their current positions. Such a move may force the stock to slide below the 83.94 obstacle and target the 81.64 level, marked by the low of May 20th.

Novartis daily

Disclaimer:

The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval.

There are risks involved with trading of cash equities. Past performance is not indicative of future results. You should consider whether you can tolerate such losses before trading. Please read the full Risk Disclosure.

Copyright 2019 JFD Group Ltd.

 

Get in Touch with Us

Sign Up For Our Newsletter
Attention icon
Trade
Responsibly

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 59.18% of the retail investor accounts lose money when trading CFDs with JFD. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Seek independent advice if necessary and review our Risk Disclosure and Privacy Policy before opening an account.

JFD Group Ltd is a company incorporated in Cyprus under registration number HE 282265, with its registered office at 70 Kyrillou Loukareos, KAKOS PREMIER TOWER, 2nd Floor, 4156 Limassol, Cyprus. The Company is authorised and regulated by the Cyprus Securities and Exchange Commission (“CySEC”) under Licence No. 150/11 and operates in full compliance with the Markets in Financial Instruments Directive (MiFID II). “JFD Brokers” is a brand name and registered trademark owned and used by the JFD Group of Companies.

JFD Group Ltd is licensed to provide the investment services of reception and transmission of orders in relation to one or more financial instruments, execution of orders on behalf of clients, dealing on own account, portfolio management and investment advice. In addition, the Company is authorised to provide the ancillary services of safekeeping and administration of financial instruments, granting credits or loans in connection with one or more financial instruments, foreign exchange services linked to the provision of investment services, and investment research and financial analysis. Clients are strongly advised to read and fully understand the Terms and Conditions of JFD Group Ltd before engaging in any activity with the Company.

Access to the Company’s trading platform and investment services is strictly prohibited for individuals under the age of 18, or below the legal age of majority in their country of residence, and for any persons who are otherwise legally incapable of entering into binding contracts under applicable laws. In the case of legal entities, access is limited to those duly incorporated and authorised to enter into legally binding agreements under the laws of their jurisdiction of incorporation, formation or domiciliation.

JFD Group Ltd may only provide services to clients resident in the European Economic Area (EEA) or in jurisdictions where the Company holds the necessary legal authorisations to do so.

The provision of investment services is restricted for residents of certain countries, including but not limited to the United States of America, Russia, Belarus, Poland, Latvia, the Czech Republic, Moldova, Montenegro, Serbia, the United Kingdom and any other jurisdiction where domestic regulations prohibit such offerings.

To provide you with the best possible experience, this site uses cookies. By continuing to browse or by clicking "Accept All Cookies", you agree to the cookie usage. Find out more in our Privacy Policy.
More options

Risk Warning: 59.18% of retail investor accounts lose money when trading CFDs with this provider.CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. Please consider our Risk Disclosure.